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SUBCLINICAL LEUKODYSTROPHY AND
INFERTILITY IN A MAN WITH A NOVEL
HOMOZYGOUS CLCN2 MUTATION
Mutations in the CLCN2 gene encoding ClC-2, a
chloride channel implicated in brain ion and water
homeostasis, have been recently associated with a rare
autosomal recessive leukoencephalopathy, character-
ized by specific MRI findings caused by chronic white
matter edema.1
Case report. A 42-year-old Italian man born from
consanguineous parents was admitted for a subclinical
leukoencephalopathy discovered during a previous
assessment for infertility. He had azoospermia,
demonstrated by repeated semen analyses since age
36 years, but noninvasive azoospermia workup had
normal results (appendix e-1 on the Neurology® Web
site at Neurology.org), and he refused testicular biopsy.
At age 39 years, pituitary MRI was performed because
repeat hormone screening had revealed slightly
increased prolactin (26.6 ng/mL [normal 4.04–15.2]).
There was no conclusive evidence of pituitary adenoma,
but, despite the lack of neurologic symptoms, white
matter signal abnormalities were incidentally found in
the brain, with a pattern consisting of prominent
T2-weighted hyperintensity in the internal capsule
posterior limbs, midbrain cerebral peduncles, and
middle cerebellar peduncles. No decreased apparent
diffusion coefficient (ADC) values were found in the
areas of abnormal T2-weighted signal. Prolactin
normalized under cabergoline therapy (0.125 mg/wk),
but semen analysis still showed azoospermia. Over a
2-year follow-up, the leukodystrophic pattern remained
unchanged, and the patient continued to have no
neurologic symptoms. When he came to our
attention, neurologic examination showed only a
positive palmomental reflex, inconstant minimal
postural hand tremor, increased deep tendon
reflexes, and bilateral Hoffmann sign. No Babinski sign
was noted. Repeat brain MRI findings are shown in the
figure. Magnetic resonance spectroscopy and pituitary
MRI were unremarkable as well as hormone
screening (he was still treated with cabergoline).
Neuro-ophthalmologic examination, including
computerized visual field testing, neuropsychological
assessment, EEG, somatosensory evoked potentials, and
EMG with nerve conduction studies, had normal
results. Motor evoked potentials showed only upper
limb central motor conduction times at the upper limit
of the normal range (7.0 ms [normal ,7.1]), while
electroretinogram (ERG), visual evoked potentials
(VEP), and brainstem auditory evoked potentials
(BAEP) were abnormal (appendix e-1). CLCN2-related
leukodystrophy was considered because of the MRI
pattern, despite normal ADC values.1 Diagnosis was
confirmed by CLCN2 sequencing, which showed
a homozygous missense mutation (c.1507G.A,
p.Gly503Arg) (appendix e-1).
Discussion. Thus far, leukodystrophy caused byCLCN2
mutations has been reported in only 6 patients (3 adult
women and 3 children).1 Age at onset is variable, rang-
ing from childhood to middle age, as are clinical fea-
tures, consisting of mild cerebellar ataxia and a varying
combination of other neurologic signs.
Our case provides evidence that individuals with
CLCN2 mutations can have no neurologic symp-
toms, despite overt brain MRI abnormalities, and
further indicates that this disease can be stable over
time (as reported in 5 out of 6 cases1). A possible
explanation for this clinical-radiologic discrepancy is
that white matter signal abnormalities represent intra-
myelinic edema,1 which may cause no prominent
axonal degeneration or dysfunction. Consistent with
this hypothesis, we found normal motor and soma-
tosensory evoked potentials, despite MRI involve-
ment of pyramidal tracts in the brainstem and
internal capsule posterior limbs. Unlike previously
reported patients,1 ADC values in the areas of abnor-
mal signal were normal or even slightly increased in
the middle cerebellar peduncles, thus suggesting that
diffusion restriction can be absent (appendix e-1).
This may depend on the size of the myelin vacuoles
and extracellular spaces, which might be larger than in
the other cases reported so far.1
Abnormal ERG and VEP further suggest that reti-
nopathy (a key finding in Clcn2-deficient mice2) and
optic pathway dysfunction (figure) are common find-
ings in this disease,1 but normal fundus and visual field
demonstrate that they can be subclinical. Similarly, neu-
rosensory hearing loss was reported in 1 case only,1 but
clearly abnormal BAEP in our patient suggest that some
degree of auditory pathway involvement may occur
more frequently than recognized so far. Follow-up will
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be necessary to establish whether these subclinical find-
ings become symptomatic over years.
Finally, this case—in the only man with CLCN2
mutations reported so far—provides the first evi-
dence that male infertility with azoospermia may
be a feature of this newly identified disease. Clcn2-
deficient mice manifest azoospermia with severe tes-
ticular degeneration,2 and the cystic fibrosis disease
gene (CFTR), which also encodes a chloride channel,
causes obstructive azoospermia in 95% of affected
men.3 We could not investigate the pathology under-
lying the lack of spermatozoa in our patient because
he refused testicular biopsy. It might be worthwhile to
verify whether other men have azoospermia associated
with autosomal-recessive CLCN2 mutations and sub-
clinical leukoencephalopathy, given that in the pre-
sent case the discovery of the leukodystrophic pattern
was incidental.
†Deceased.
From the Fondazione IRCCS Istituto Neurologico Carlo Besta (D.D.B.,
D.P., M.S., L.F., C.C., S.C., A.S., S.N., F.T., E.S.), Milan; University
ofMilan (S.B., N.B.); Fondazione IRCCSCa’GrandaOspedaleMaggiore
Policlinico (S.B., N.B.), Milan; the Scientific Institute IRCCS E. Medea
(N.B.), Bosisio Parini; and the Second University of Naples (G.T.), Italy.
Author contributions: Dr. Di Bella collected and analyzed laboratory
data, contributed to writing the manuscript, and revised it for important
intellectual content. Dr. Pareyson acquired and analyzed clinical data
and revised the manuscript. Dr. Savoiardo analyzed MRI data and
suggested the proper diagnosis. Dr. Farina collected and analyzed MRI
data and contributed to writing the manuscript. Dr. Ciano collected and
analyzed neurophysiologic data and contributed to writing the manuscript.
Dr. Caldarazzo performed genetic analysis. Dr. Sagnelli collected data and
revised the manuscript. Dr. Bonato acquired and analyzed data and
contributed to writing the manuscript. Dr. Nava performed quantitative
analysis of diffusion-weighted MRI. Prof. Bresolin acquired and analyzed
data. Prof. Tedeschi acquired and analyzed data. Dr. Taroni contributed
to writing and revising the manuscript for important intellectual content.
Dr. Salsano drafted the manuscript and made substantial contributions to
acquisition and interpretation of data and study coordination.
Acknowledgment: The authors thank Mario Savoiardo, an Italian
pioneer in neuroradiology, who died during the revision process of this
article, for his help, insightful comments, and diagnoses. The authors
and his friends around the world will miss him.
Study funding: Supported by Italian Ministry of Health grant RF-2009-
1539841 to F.T.
Disclosure: The authors report no disclosures relevant to the manu-
script. Go to Neurology.org for full disclosures.
Received December 13, 2013. Accepted in final form May 12, 2014.
Correspondence to Dr. Taroni: franco.taroni@istituto-besta.it
© 2014 American Academy of Neurology
1. Depienne C, Bugiani M, Dupuits C, et al. Brain white matter
oedema due to ClC-2 chloride channel deficiency: an obser-
vational analytical study. Lancet Neurol 2013;12:659–668.
2. Edwards MM, Marín de Evsikova C, Collin GB, et al. Pho-
toreceptor degeneration, azoospermia, leukoencephalopa-
thy, and abnormal RPE cell function in mice expressing
an early stop mutation in CLCN2. Invest Ophthalmol Vis
Sci 2010;51:3264–3272.
3. Chen H, Ruan YC, Xu WM, Chen J, Chan HC. Regula-
tion of male fertility by CFTR and implications in male
infertility. Hum Reprod Update 2012;18:703–713.
Figure MRI
Axial fluid-attenuated inversion recovery images (A–D) show hyperintensity of middle cerebellar peduncles, cerebral pe-
duncles, and posterior limb of the internal capsules (arrows in A, B, and C). Hyperintensities are also present in the cortico-
spinal tracts (A), in the splenium of the corpus callosum (small arrows in C), in the centra semiovalia (D), and in the chiasm (not
shown). The slight hyperintensity of cerebral peduncles and posterior limb of internal capsules on diffusion-weighted MRI
(arrows in E and F) is not confirmed on apparent diffusion coefficient (ADC) map (arrows in G and H) (see appendix e-1 for
quantitative ADC values).
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